REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 83 filers reported holding REVANCE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.20 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $322,000 | -95.6% | 12,183 | -96.5% | 0.00% | -94.4% |
| Q1 2017 | $7,280,000 | +0.5% | 350,000 | 0.0% | 0.02% | -10.0% |
| Q4 2016 | $7,245,000 | +27.7% | 350,000 | 0.0% | 0.02% | +25.0% |
| Q3 2016 | $5,674,000 | +11.3% | 350,000 | -6.7% | 0.02% | +14.3% |
| Q2 2016 | $5,100,000 | -22.1% | 375,000 | 0.0% | 0.01% | -22.2% |
| Q1 2016 | $6,548,000 | -48.9% | 375,000 | 0.0% | 0.02% | -47.1% |
| Q4 2015 | $12,810,000 | +144.9% | 375,000 | +113.3% | 0.03% | +126.7% |
| Q3 2015 | $5,231,000 | – | 175,773 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $156,130,000 | 32.47% |
| Camber Capital Management LP | 630,000 | $21,420,000 | 1.40% |
| Granite Point Capital Management, L.P. | 50,000 | $1,700,000 | 1.17% |
| Rhenman & Partners Asset Management AB | 82,000 | $2,788,000 | 0.83% |
| Geduld E E | 25,001 | $850,000 | 0.53% |
| Pier Capital, LLC | 106,985 | $3,637,000 | 0.52% |
| Ghost Tree Capital, LLC | 20,000 | $680,000 | 0.48% |
| ArrowMark Colorado Holdings LLC | 433,457 | $14,738,000 | 0.42% |
| Polar Capital LLP | 577,042 | $19,618,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,500 | $8,721,000 | 0.35% |